SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Patient MonitoringBlood Glucose Monitoring

PUBLISHER: Market Glass, Inc. | PRODUCT CODE: 2148195

Cover Image

PUBLISHER: Market Glass, Inc. | PRODUCT CODE: 2148195

Glucose Monitoring Devices

PUBLISHED:
PAGES: 362 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Team License: Up to 10 users)
USD 11115
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Glucose Monitoring Devices Market to Reach US$33.0 Billion by 2032

The global market for Glucose Monitoring Devices estimated at US$15.7 Billion in the year 2025, is expected to reach US$33.0 Billion by 2032, growing at a CAGR of 11.2% over the analysis period 2025-2032. Continuous Monitoring Devices Type, one of the segments analyzed in the report, is expected to record a 12.5% CAGR and reach US$22.7 Billion by the end of the analysis period. Growth in the Self-Monitoring Devices Type segment is estimated at 8.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.3 Billion While China is Forecast to Grow at 14.9% CAGR

The Glucose Monitoring Devices market in the U.S. is estimated at US$4.3 Billion in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$7.0 Billion by the year 2032 trailing a CAGR of 14.9% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.3% and 10.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.0% CAGR.

Global Glucose Monitoring Devices Market - Key Trends and Drivers Summarized

The market for glucose monitoring devices is experiencing rapid growth, fueled by technological advancements, increasing diabetes prevalence, and a rising emphasis on proactive health management. Global diabetes rates are climbing due to factors such as obesity, aging populations, and lifestyle habits such as poor diet and inactivity, amplifying the need for effective monitoring solutions. Continuous Glucose Monitors (CGMs) have evolved significantly, offering high accuracy and simplicity beyond their original insulin therapy support.

Continued market expansion hinges on technological progress, healthcare integration, and the escalating diabetes burden worldwide. Innovations like non-invasive technologies, AI integration, and wearable devices are shaping the future landscape, promising enhanced diabetes management and patient care. As these solutions become more accessible, they're expected to significantly improve global diabetes management, especially as healthcare infrastructure strengthens in emerging economies, presenting ample growth opportunities for manufacturers.

Key market drivers and trends include technological leaps such as CGM systems, which provide real-time insights into glucose levels, and the integration of AI into glucose monitoring, AI is increasingly being incorporated into glucose monitoring systems to enhance the predictive accuracy of devices. These systems can analyze data over time to predict future trends in glucose levels, enabling preemptive management of potential issues. Artificial Intelligence (AI) is reshaping many aspects of healthcare, including diabetes management Government policies promoting better screening and monitoring, alongside patient education emphasizing self-monitoring, further drive adoption. Wearable glucose monitors that seamlessly integrate with everyday life are gaining traction. These devices continuously track glucose levels and offer the convenience of not having to perform multiple daily finger-prick tests.

SCOPE OF STUDY:

The report analyzes the Glucose Monitoring Devices market by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Continuous Monitoring Devices Type, Self-Monitoring Devices Type); Indication (Diabetes Type I Indication, Diabetes Type II Indication, Gestational Diabetes Indication); End-Use (Hospitals End-Use, Clinics End-Use, Home Care End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

  • Abbott Diabetes Care, Inc.
  • ACON Laboratories, Inc.
  • AgaMatrix, Inc.
  • Alive Technologies Pty. Ltd.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • Beurer GmbH
  • Dexcom, Inc.
  • GlySens Inc.
  • LifeScan, Inc.
  • Medtronic plc
  • Nova Biomedical Corporation
  • Omron Healthcare Co., Ltd.
  • Roche Diagnostics
  • Senseonics Holdings, Inc.
  • Terumo Corporation
  • Trividia Health, Inc.
  • Ypsomed Holding AG

WHAT SETS THIS REPORT APART FROM OTHERS?

Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.

Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.

Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.

Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.

Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.

Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Show more
Product Code: MG3420

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Glucose Monitoring Devices - Global Key Competitors Percentage Market Share in 2026 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for 32 Players Worldwide in 2026 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Diabetes Globally Strengthens Business Case for Glucose Monitoring Devices
    • Growing Awareness of the Benefits of Regular Glucose Monitoring Drives Adoption Across Various Demographics
    • Growth in Home Healthcare Services Generates Demand for User-Friendly Glucose Monitoring Solutions
    • Innovations in Non-Invasive Glucose Monitoring Technology Spurs Market Growth
    • Expansion of Telemedicine and Remote Monitoring Sustains Growth in Glucose Monitoring Devices Market
    • Integration of Artificial Intelligence in Glucose Monitoring Enhances Data Accuracy and Insights
    • Technological Developments in Smartphone-Connected Glucose Monitors Propel Market Expansion
    • Emphasis on Preventive Healthcare Drives Adoption of Continuous Glucose Monitoring Solutions
    • Adoption of Glucose Monitoring in Pediatric Care Expands Addressable Market Opportunity
    • Increasing Use of Glucose Monitoring in Fitness and Wellness Accelerates Demand for Multifunctional Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Glucose Monitoring Devices Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
    • TABLE 2: World Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 3: World Historic Review for Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 4: World 13-Year Perspective for Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
    • TABLE 5: World Recent Past, Current & Future Analysis for Continuous Monitoring Devices Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 6: World Historic Review for Continuous Monitoring Devices Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 7: World 13-Year Perspective for Continuous Monitoring Devices Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 8: World Recent Past, Current & Future Analysis for Self-Monitoring Devices Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 9: World Historic Review for Self-Monitoring Devices Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 10: World 13-Year Perspective for Self-Monitoring Devices Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 11: World Recent Past, Current & Future Analysis for Diabetes Type I Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 12: World Historic Review for Diabetes Type I Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 13: World 13-Year Perspective for Diabetes Type I Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 14: World Recent Past, Current & Future Analysis for Diabetes Type II Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 15: World Historic Review for Diabetes Type II Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 16: World 13-Year Perspective for Diabetes Type II Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 17: World Recent Past, Current & Future Analysis for Gestational Diabetes Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 18: World Historic Review for Gestational Diabetes Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 19: World 13-Year Perspective for Gestational Diabetes Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 21: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 22: World 13-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 23: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 24: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 25: World 13-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 26: World Recent Past, Current & Future Analysis for Home Care End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 27: World Historic Review for Home Care End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 28: World 13-Year Perspective for Home Care End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032

III. MARKET ANALYSIS

  • UNITED STATES
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 30: USA Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 31: USA 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 32: USA Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 33: USA Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 34: USA 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 35: USA Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 36: USA Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 37: USA 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 39: Canada Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 40: Canada 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 42: Canada Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 43: Canada 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 45: Canada Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 46: Canada 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • JAPAN
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 48: Japan Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 49: Japan 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 51: Japan Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 52: Japan 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 54: Japan Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 55: Japan 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • CHINA
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 57: China Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 58: China 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 59: China Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 60: China Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 61: China 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 62: China Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 63: China Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 64: China 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • EUROPE
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 66: Europe Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 67: Europe 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 69: Europe Historic Review for Glucose Monitoring Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 70: Europe 13-Year Perspective for Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 72: Europe Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 73: Europe 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 75: Europe Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 76: Europe 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • FRANCE
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 78: France Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 79: France 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 80: France Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 81: France Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 82: France 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 83: France Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 84: France Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 85: France 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • GERMANY
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 87: Germany Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 88: Germany 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 90: Germany Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 91: Germany 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 93: Germany Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 94: Germany 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 96: Italy Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 97: Italy 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 99: Italy Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 100: Italy 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 102: Italy Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 103: Italy 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • UNITED KINGDOM
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 105: UK Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 106: UK 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 107: UK Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 108: UK Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 109: UK 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 110: UK Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 111: UK Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 112: UK 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 114: Spain Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 115: Spain 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 117: Spain Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 118: Spain 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 120: Spain Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 121: Spain 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 123: Russia Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 124: Russia 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 126: Russia Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 127: Russia 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 129: Russia Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 130: Russia 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 133: Rest of Europe 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 136: Rest of Europe 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 139: Rest of Europe 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • ASIA-PACIFIC
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Glucose Monitoring Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 142: Asia-Pacific 13-Year Perspective for Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 145: Asia-Pacific 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 148: Asia-Pacific 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 151: Asia-Pacific 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
  • AUSTRALIA
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 153: Australia Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 154: Australia 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 156: Australia Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 157: Australia 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 159: Australia Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 160: Australia 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
  • INDIA
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 162: India Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 163: India 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 164: India Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 165: India Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 166: India 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
    • TABLE 167: India Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 168: India Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 169: India 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 171: South Korea Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 172: South Korea 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 174: South Korea Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 175: South Korea 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 177: South Korea Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 178: South Korea 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
  • LATIN AMERICA
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 189: Latin America Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 190: Latin America 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 192: Latin America Historic Review for Glucose Monitoring Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 193: Latin America 13-Year Perspective for Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 195: Latin America Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 196: Latin America 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 198: Latin America Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 199: Latin America 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 201: Argentina Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 202: Argentina 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 204: Argentina Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 205: Argentina 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 207: Argentina Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 208: Argentina 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 210: Brazil Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 211: Brazil 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 213: Brazil Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 214: Brazil 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 216: Brazil Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 217: Brazil 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 219: Mexico Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 220: Mexico 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 222: Mexico Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 223: Mexico 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 225: Mexico Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 226: Mexico 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 229: Rest of Latin America 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 232: Rest of Latin America 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 235: Rest of Latin America 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • MIDDLE EAST
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 237: Middle East Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 238: Middle East 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 240: Middle East Historic Review for Glucose Monitoring Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 241: Middle East 13-Year Perspective for Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 243: Middle East Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 244: Middle East 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 246: Middle East Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 247: Middle East 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 249: Iran Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 250: Iran 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 252: Iran Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 253: Iran 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 255: Iran Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 256: Iran 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 258: Israel Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 259: Israel 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 261: Israel Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 262: Israel 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 264: Israel Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 265: Israel 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 268: Saudi Arabia 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 271: Saudi Arabia 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 274: Saudi Arabia 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 276: UAE Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 277: UAE 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 279: UAE Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 280: UAE 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 282: UAE Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 283: UAE 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 286: Rest of Middle East 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 289: Rest of Middle East 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 292: Rest of Middle East 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032
  • AFRICA
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 294: Africa Historic Review for Glucose Monitoring Devices by End-Use - Hospitals End-Use, Clinics End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 295: Africa 13-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Home Care End-Use for the Years 2020, 2026 & 2032
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 297: Africa Historic Review for Glucose Monitoring Devices by Type - Continuous Monitoring Devices Type and Self-Monitoring Devices Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 298: Africa 13-Year Perspective for Glucose Monitoring Devices by Type - Percentage Breakdown of Value Sales for Continuous Monitoring Devices Type and Self-Monitoring Devices Type for the Years 2020, 2026 & 2032
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 300: Africa Historic Review for Glucose Monitoring Devices by Indication - Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 301: Africa 13-Year Perspective for Glucose Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Diabetes Type I Indication, Diabetes Type II Indication and Gestational Diabetes Indication for the Years 2020, 2026 & 2032

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!